Effect of the dopamine D(1/5) antagonist SCH 23390 on the acquisition of conditioned fear

• Published in: Pharmacology, biochemistry and behavior biochemistry and behavior, 2000-07, Vol.66 (3), p.573-578
• Main Authors: Inoue, T, Izumi, T, Maki, Y, Muraki, I, Koyama, T
• Format: Article
• Language: English
• Subjects: Animals; Benzazepines - pharmacology; Conditioning (Psychology) - drug effects; Dopamine Antagonists - pharmacology; Fear - drug effects; Fear - physiology; Fear - psychology; Male; Pain Measurement - drug effects; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 - antagonists & inhibitors; Receptors, Dopamine D5
• ISSN: 0091-3057
• DOI: 10.1016/S0091-3057(00)00254-9

The authors previously reported that typical and atypical antipsychotic drugs inhibited the acquisition but not expression of conditioned fear. The present study examined the effects of the selective dopamine D(1/5) agonist (SKF 38393) and antagonist (SCH 23390) on the acquisition and expression of conditioned fear. Drugs were administered subcutaneously to male Sprague-Dawley rats 30 min before foot shock (2.5 mA for 5 min). Twenty-four hours after foot shock, rats were again placed and observed in the shock chamber without shocks (conditioned fear). Freezing behavior induced by conditioned fear, an index of anxiety or fear, was recorded using a time-sampling procedure. SCH 23390 (0.1-1 mg/kg) inhibited the acquisition of conditioned freezing. The administration of SCH 23390 at a dose of 0.1 mg/kg 30 min after foot shock did not affect conditioned freezing. Taken together, it is concluded that D(1/5) antagonism inhibits the acquisition of conditioned fear. SKF 38393 (3-20 mg/kg) failed to change the acquisition of conditioned fear. SCH 23390 or SKF 38393 administered prior to testing did not reduce the expression of conditioned fear. These results suggest that D(1/5) receptors may play a role in the development of fear or anxiety.